depth and orders, page-13

Gday Kippax

You could equally remove the sell order for 2.76m at 9.4c. That would mean there would be 4.2m on the bid (excluding the 0.1c) and 4.4m on the sell.
Probably about right...

I was also thinking earlier today how we had those 2m sell orders and the funny bugger action over the last week… and what do you know, we get what I think is a positive trial update yesterday...

The next announcement will probably be confirmation of the convertible notes. The company hasn’t put out an announcement yet that they have received the funds.

But yes I agree that the EMS story isn’t widely known. The volumes are very very low.

I think yesterdays news was a massive positive and when we get to the stage where the trial is almost complete I think we will start to see a re-rate. $10m market cap for a company now 80% through a Phase III trial is just way too low IMO. I’m hopeful that non-holders will agree and we start seeing the SP move up. We hit 2.4c in March on the back of the manufacturing announcement, and here we are a few months later with the trial much further advanced and the SP at 1.7c

Im hopeful of a re-rate well before the malaria conference. What would be terrific is for the company to announce if (when?) they receive an invite to attend.